Convexity Labs

RYAN

Convexity Analyst · RYAN
Speculativemedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: RYAN (Ryan Specialty Holdings, Inc.)

Date: 2026-06-20 Price: $34.97

1. Structural Readiness

  • Conservative Entry: Not yet defined (requires breakout confirmation).
  • Aggressive/Pre-Breakout Entry: Not applicable for a confirmed entry; current price ($34.97) represents the consolidation range.
  • Breakout Level: Not yet established (requires price to close above the consolidation high).
  • Current Price: $34.97.
  • Extension: Not applicable (price is in consolidation, not extended).
  • ATR Context: Current ATR is 4.5% (High). This falls within the historical "sweet spot" (4–6%) for structural quality, suggesting sufficient volatility to support a move but not so extreme as to indicate a severe-loser profile.

2. Thesis Layer

As of 2026-06-20, there is no named secular thesis driving this specific setup. This is a TACTICAL, setup-led name. The investment case must be judged strictly on the quality of the structural setup (the forming coil) and the immediate business fundamentals disclosed in the most recent earnings and filings. No macro or thematic thesis should be invented to support the trade; the conviction rests on the alignment of management's restructuring execution with the technical structure.

3. Business Overview

Ryan Specialty Holdings, Inc. operates as a specialized insurance intermediary, distinct from generalist brokers.

  • Core Function: The company acts as the largest delegated underwriting authority provider (E6) and the second-largest wholesale broker (E5). It serves global retailers and tens of thousands of retail brokers in the U.S.
  • Market Focus: A significant majority of premiums placed are in the E&S (Excess & Surplus) market, including Lloyd's of London. In 2025, 78% of total premiums placed were in the E&S market (E16). The company assists in placing complex, high-hazard, or hard-to-place risks (E9, E11, E15).
  • Recent Performance & Guidance (as of April 30, 2026):
  • Revenue: Management is guiding to mid-single-digit organic revenue growth for the full year (E1).
  • Headwinds: The guidance incorporates property rate declines of 25% to 35% for the most catastrophe-exposed lines, leading to a "meaningful decline" in the property book for the full year (E2).
  • Growth Trajectory: Q2 organic growth is assumed to be near 0%, with significant uncertainty regarding property trends (E4).
  • Margins: Full-year adjusted EBITDA margin is guided to be down approximately 100 to 150 basis points year-over-year (E3).
  • Restructuring ("Empower Program"): Initiated in Q1 2026, this three-year program aims to streamline operations and optimize scale.
  • Costs: Estimated $160 million in cumulative one-time charges through 2028 (E8, E13).
  • Savings: Expected to generate $80 million in annual run-rate savings by 2029, with savings ramping through 2027 and 2028 (E8, E13).
  • Customer Concentration: In 2025, revenue from the Top 100 firms expanded faster than the company's organic revenue growth rate of 10.1% (E14).

4. Archetype and Conviction

  • Archetype: Quality Compounder (with a near-term inflectionary restructuring phase).
  • *Fit:* The company is a market leader in a specialized niche (E&S/delegated underwriting) with a clear path to margin expansion via the "Empower Program." However, the current financial spine shows a deliberate margin compression (100-150 bps decline) and flat growth (near 0% in Q2) as it navigates a difficult property market and executes a costly restructuring.
  • Conviction Stack:
  • Thesis Strength: Low (No named secular thesis; purely tactical).
  • Evidence Quality: High. Management has provided specific, quantified guidance on revenue, margins, and restructuring costs/savings (E1-E4, E8, E13).
  • Structural Quality: Moderate to High. The ATR of 4.5% indicates a healthy volatility environment for a setup. The "forming" coil suggests the market is digesting the negative guidance (margin decline, flat growth) and the restructuring costs.
  • Setup Readiness: Partial. The coil is forming, not confirmed. The price is holding above the support level, but the breakout has not fired.
  • Rerating Potential: Dependent on the successful execution of the Empower Program and the stabilization of the property book. The market may re-rate the stock once the $160M charge is fully recognized and the $80M savings trajectory becomes visible.

5. Invalidations, Strengtheners, and Gaps

  • Strengtheners: A confirmed breakout above the consolidation high (firing the coil). Fundamentally, evidence of Q3/Q4 organic growth accelerating beyond the "near 0%" Q2 assumption or a clear signal that the property book decline is stabilizing would strengthen the case.
  • Gaps in Evidence:
  • Specific Breakout Level: The exact price level for the breakout is not provided in the evidence block.
  • Valuation Metrics: No P/E, EV/EBITDA, or P/S multiples are provided in the evidence to contextualize the $34.97 price relative to historical or peer valuations.
  • Cash Flow Details: While the program is funded by operating cash flow, specific free cash flow generation figures for 2026 are not detailed.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management guidance for mid-single-digit organic growth and $80M annual savings by 2029 via Empower Program; 78% of premiums in high-growth E&S market; current price holding above structural support with 4.5% ATR indicating healthy volatility. Key risks: Q2 organic growth near 0% with uncertainty on property trends; 100-150 bps EBITDA margin decline; $160M in restructuring charges impacting near-term earnings; potential for property rate declines to exceed 35% guidance. Sizing hint: Position size should reflect the "forming" status of the coil; treat as a partial position until breakout confirmation. Expected path: Management expects the restructuring charges to be fully recognized by 2028, followed by margin expansion as savings ramp, potentially leading to a re-rating once the "near 0%" growth phase passes. Expected horizon: 6 to 12 months for the setup to resolve (breakout or invalidation) and 24 months for the fundamental thesis (savings realization) to mature.

Loading chart...
Exhibit 1: RYAN daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for RYAN.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for RYAN.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: